“Does there come a point where the company has to think differently? Maybe thinking about investment levels differently or how to run the business differently?” Teva’s CEO Richard Francis was asked in January, just ten days after the former Biogen and Sandoz exec took up the role.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?